Your browser doesn't support javascript.
loading
Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease.
Twardowski, Laura; Cheng, Fei; Michaelsen, Jens; Winter, Stefan; Hofmann, Ute; Schaeffeler, Elke; Müller, Simon; Sonnenberg, Maike; Steuer, Kristin; Ott, German; Schwab, Matthias; Franke, Ulrich F W; Torzewski, Michael.
Afiliación
  • Twardowski L; Department of Laboratory Medicine, Robert-Bosch-Hospital, Stuttgart, Germany (L.T., F.C., M.T.).
  • Cheng F; Department of Laboratory Medicine, Robert-Bosch-Hospital, Stuttgart, Germany (L.T., F.C., M.T.) Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Michaelsen J; Department of Cardiovascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany (J.M., U.W.F.).
  • Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Hofmann U; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Müller S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Sonnenberg M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Steuer K; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
  • Ott G; Department of Pathology, Robert-Bosch-Hospital, Stuttgart, Germany (G.O.).
  • Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.) Department of Clinical Pharmacology, University Hospital, Tuebingen, Germany (M.S.).
  • Franke UF; Department of Cardiovascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany (J.M., U.W.F.).
  • Torzewski M; Department of Laboratory Medicine, Robert-Bosch-Hospital, Stuttgart, Germany (L.T., F.C., M.T.) Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany (F.C., S.W., U.H., E.S., S., M.S., K.S., M.S., M.T.).
J Am Heart Assoc ; 4(10): e002156, 2015 Oct 16.
Article en En | MEDLINE | ID: mdl-26475297
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Válvula Aórtica / Calcinosis / Enfermedades de las Válvulas Cardíacas / Lipoproteínas LDL Tipo de estudio: Etiology_studies Límite: Aged80 Idioma: En Revista: J Am Heart Assoc Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Válvula Aórtica / Calcinosis / Enfermedades de las Válvulas Cardíacas / Lipoproteínas LDL Tipo de estudio: Etiology_studies Límite: Aged80 Idioma: En Revista: J Am Heart Assoc Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido